Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 17, 2013Nucleic Acids ResearchOpen Access

BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers

View Full Paper
Ask AI
Bookmark
Share

Authors

NBNiamh E. BuckleyQueen's University BelfastCTC. B. Nic An tSaoirQueen's University BelfastJBJaine K. BlayneyQueen's University Belfast

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Buckley et al. (2013) studied this question.

synapsesocial.com/papers/6aa67fd924014aaf7fdd5f39https://doi.org/10.1093/nar/gkt626
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts2005 · 854 citations
  2. 2Molecular Basis for Estrogen Receptor Deficiency in BRCA1-Linked Breast Cancer2007 · 194 citations
  3. 3Synthetic Lethality through Combined Notch–Epidermal Growth Factor Receptor Pathway Inhibition in Basal-Like Breast Cancer2010 · 92 citations
  4. 4Repression of Mammary Stem/Progenitor Cells by p53 Is Mediated by Notch and Separable from Apoptotic Activity2010 · 70 citations